US2015306003A1PendingUtilityA1
Injectable Amino-acid Composition
Individually held — no corporate assignee on recordPriority: May 20, 2009Filed: Jul 6, 2015Published: Oct 29, 2015
Est. expiryMay 20, 2029(~2.8 yrs left)· nominal 20-yr term from priority
Inventors:Donna M. Tozzi
A61K 8/447A61K 8/4946A61K 31/4415A61K 8/66A61K 2800/91A61Q 19/00A61K 8/44A61K 31/401C12Y 304/24069A61K 8/64A61K 2800/5922A61Q 19/08A61K 31/198A61K 9/0019A61K 8/60A61K 31/4172A61K 38/4893A61K 31/7008A61K 8/4926A61K 8/4913
28
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An injectable amino-acid composition acts naturally to fuel collagen synthesis, which retards aging and helps to clear cellular decay while accelerating the cell division that promotes healthy, younger looking skin. The amino-acid composition includes carnosine. The composition is injected into the dermis of patients. The composition can be used in conjunction with botulinum toxin and fillers to enhance their effectiveness and extend their usefulness.
Claims
exact text as granted — not AI-modifiedI claim:
1 . A method for promoting skin repair, which comprises delivering an amino-acid composition to a dermis of a patient at a given site during a given treatment, said amino-acid composition including proline.
2 . The method according to claim 1 , wherein said amino-acid composition includes an amino acid selected from the group consisting of lysine, arginine, leucine, isoleucine, and methionine.
3 . The method according to claim 1 , wherein said amino-acid composition includes at least one of glucosamine, pyridoxine, and carnosine.
4 . The method according to claim 1 , wherein the dermis receiving the amino-composition is an area to be treated.
5 . The method according to claim 1 , wherein said dermis is located in an anatomical location selected form the group consisting of a face, skin around eyes, cheeks, upper lip, oral commissures, jaw line, neck, décolleté, and cleavage.
6 . The method according to claim 1 , which further comprises injecting dermal tissue surrounding the dermis with botulinum toxin after delivering the amino-acid composition.
7 . The method according to claim 1 , which further comprises injecting dermal tissue surrounding the dermis with a dermal filler after delivering the amino-acid composition.
8 . The method according to claim 1 , which further comprises injecting a volume no greater than 0.5 mL of the amino-acid composition at a given site.
9 . The method according to claim 1 , wherein the delivering of the amino-acid composition is performed by injecting the dermis.
10 . The method according to claim 1 , which further comprises performing the delivering step on a same day but before injecting botulinum toxin or a filler.
11 . The method according to claim 1 , which further comprises performing the delivering step after injecting botulinum toxin or a filler.
12 . The method according to claim 11 , wherein the delivering step is performed at least seven days after injecting the botulinum toxin or the filler.
13 . The method according to claim 1 , wherein said amino-acid composition further includes Glucosamine HCl, Pyridoxine HCl, Lysine HCl, Arginine HCl, Leucine, Isoleucine, Methionine, and Carnosine.
14 . The method according to claim 1 , wherein said amino-acid composition has a pH between 6.0 and 7.4.
15 . The method according to claim 1 , wherein said proline has a weight percentage in said amino-acid composition of 0.0014.
16 . The method according to claim 8 , which comprises injecting at least 0.1 mL of said amino-acid composition at the site.
17 . The method according to claim 16 , which comprises further injecting the site with at least 0.1 mL of said amino-acid composition, a total volume of said amino-acid composition not exceeding 0.5 mL.
18 . A method for cosmetically improving skin of a patient, which comprises injecting a therapeutic amount of an amino-acid composition into dermis of the patient at a treatable location, said amino-acid composition including proline; said treatable location being selected from the group consisting of a face of the patient, a neck of the patient, a décolleté of the patient, and a back of a hand of the patient.Join the waitlist — get patent alerts
Track US2015306003A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.